Cognitive behavioural therapy (CBT) for people with psychosis not taking antipsychotic medication: a randomised controlled trial

ISRCTN ISRCTN29607432
DOI https://doi.org/10.1186/ISRCTN29607432
Protocol serial number 7991
Sponsor Greater Manchester West Mental Health NHS Foundation Trust (UK)
Funder National Institute for Health Research (NIHR) (UK) - Central Commissioning Facility (CCF)
Submission date
21/10/2010
Registration date
21/10/2010
Last edited
11/02/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Anthony Morrison
Scientific

Psychology Department
Prestwich Hospital
Bury New Road
Prestwich
Manchester
M25 3BL
United Kingdom

Email tony.morrison@manchester.ac.uk

Study information

Primary study designInterventional
Study designMulticentre randomised interventional treatment trial
Secondary study designRandomised controlled trial
Scientific title
Study acronymACTION (Assessment of Cognitive Therapy Instead of Neuroleptics)
Study objectivesComparing cognitive behavioural therapy (CBT) with treatment as usual for people with psychosis who are not taking antipsychotic medication
Ethics approval(s)MREC approved (ref: 09/H1014/53)
Health condition(s) or problem(s) studiedTopic: Mental Health Research Network; Subtopic: Psychosis; Disease: Psychosis
InterventionCognitive therapy based on the cognitive model outlined by Morrison (2001).

Follow up length: 18 months
Study entry: single randomisation only
Intervention typeOther
Primary outcome measure(s)

PANSS, measured at all assessments

Key secondary outcome measure(s)

1. Psychotic Symptom Rating Scales (PSYRATS), measured at all assessments
2. Questionnaire about the Process of Recovery (QPR), measured at all assessments

Completion date15/02/2013

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration80
Key inclusion criteriaParticipants in all phases will:
1. Be in contact with mental health services
2. Have an identified care coordinator
3. Either meet International Classification of Diseases-10 (ICD-10) criteria for schizophrenia, schizoaffective disorder or delusional disorder or meet entry criteria for an early intervention for psychosis service (operationally defined using Positive And Negative Symptom Scales [PANSS]) in order to allow for diagnostic uncertainty in early phases of psychosis
4. Either have at least 6 months without antipsychotic medication and experiencing continuing symptoms OR never have received antipsychotics and be currently refusing
5. Score at least 4 on PANSS delusions or hallucinations or, score 5 on suspiciousness/persecution, conceptual disorganisation or grandiosity
6. Aged 16 - 65 years, either sex
Key exclusion criteria1. Current receipt of antipsychotic medication
2. Moderate to severe learning disability
3. Organic impairment
4. Non-English speaking (since this would prevent the use of standardised assessment instruments)
5. Inpatient/acute psychiatric care needed
6. Previous CBT for psychosis or, previous CBT for other disorders in the last 2 years
7. Without a care coordinator
8. Any substance dependency
Date of first enrolment15/02/2010
Date of final enrolment15/02/2013

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Psychology Department
Manchester
M25 3BL
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 19/04/2014 Yes No